• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ROCHE DIAGNOSTICS COAGUCHEK ® XS SYSTEM; PROTHROMBIN TIME TEST STRIPS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ROCHE DIAGNOSTICS COAGUCHEK ® XS SYSTEM; PROTHROMBIN TIME TEST STRIPS Back to Search Results
Catalog Number 04625358019
Device Problem Incorrect Or Inadequate Test Results (2456)
Patient Problem Paralysis (1997)
Event Date 01/16/2018
Event Type  Injury  
Manufacturer Narrative
(b)(4).This event occurred in (b)(6).
 
Event Description
The patient complained of "wrong results" from coaguchek xs meter serial number (b)(4).The patient alleged that based on the "wrong results" she took the wrong coumadin and coraspin dosage and then suffered from paralysis on one side of her body.Information was provided as "the patient had already on the left side of her body a paralysis and now she have on both side a paralysis".It was unclear when the paralysis occurred.Clarification was requested but was not provided.The patient was then admitted to the intensive care unit.Multiple requests for additional information about the event were made, but no additional information was provided.On (b)(6) 2018 at 08:00 pm, the result from the meter was 5.1 inr.On (b)(6) 2018 at 08:10 pm, the result from the meter was 3.7 inr.The same finger was used.On (b)(6) 2018 at 09:00 pm, the result in the laboratory was 2.1 inr.The laboratory method was not provided.On (b)(6) 2018 at 08:00 pm, the result from the meter was 2.1 inr.The patient then took 2.5 mg of coumadin and 100 mg of coraspin.On (b)(6) 2018 at 06:00 pm, the result from the meter was 3.4 inr.On (b)(6) 2018 at 09:00 pm, the result in the laboratory was 2.04 inr.The laboratory method was not provided.On (b)(6) 2018 at 00:00 am, the result in the laboratory was 2.0 inr.The laboratory method was not provided.On (b)(6) 2018 at 00:30 am, the result from the meter as 2.0 inr.The patient then took 2.5 mg of coumadin and 100 mg of coraspin.On (b)(6) 2018 at 11:00 am, the result in the laboratory was 2.15 inr.The laboratory method was not provided.The therapeutic range was 2.0-3.0 inr.The patient is no longer taking coumadin.Routine retention testing is performed.Retention testing data is reviewed and appropriate actions are taken as needed.Retention material complies with specification.The meter was checked and was found to be working properly.The patient was given a new meter.
 
Manufacturer Narrative
On (b)(6) 2018 at 09:00 pm the laboratory method was "diapt as reaktif".
 
Manufacturer Narrative
Relevant retention test strips (lot 250323) were tested in comparison with the master lot coaguchek xs pt.For this purpose two human blood samples from marcumar donors and two internal reference meters were used.Retention samples were acceptable and there were no error messages.The investigation was unable to find a definitive root cause.
 
Manufacturer Narrative
The customer's returned meter was tested with retention test strips in comparison to the current master lot strips.Two human blood samples from warfarin donors and internal reference meters were used.  testing results:  donor #1: master lot and reference meter: 2.7 inr , donor #1: customer meter and retention test strip: 2.2 inr.Donor #2: master lot and reference meter: 3.0 inr  , donor #2: customer meter and retention test strip: 2.6 inr .The returned material and the retention material meet the specification. .
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
COAGUCHEK ® XS SYSTEM
Type of Device
PROTHROMBIN TIME TEST STRIPS
Manufacturer (Section D)
ROCHE DIAGNOSTICS
9115 hague road
indianapolis IN 46250 0457
Manufacturer (Section G)
ROCHE DIAGNOSTICS GMBH
sandhoferstrasse 116
na
mannheim (baden-wurttemberg) 68305
GM   68305
Manufacturer Contact
michael leslie
9115 hague road
na
indianapolis, IN 46250
3175214343
MDR Report Key7302211
MDR Text Key101171709
Report Number1823260-2018-00597
Device Sequence Number1
Product Code GJS
Combination Product (y/n)N
Reporter Country CodeTU
PMA/PMN Number
K062925
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type consumer,foreign
Reporter Occupation Patient
Type of Report Initial,Followup,Followup,Followup
Report Date 05/02/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Lay User/Patient
Device Catalogue Number04625358019
Device Lot Number250323
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Initial Date Manufacturer Received 02/02/2018
Initial Date FDA Received02/28/2018
Supplement Dates Manufacturer Received02/02/2018
02/02/2018
02/02/2018
Supplement Dates FDA Received04/11/2018
05/01/2018
05/02/2018
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage N
Patient Sequence Number1
Treatment
CORASPIN; COUMADIN
Patient Outcome(s) Other;
Patient Age73 YR
Patient Weight75
-
-